The Clorox Company

The Clorox Company

CLXNYSE / NASDAQConsumer DefensiveLarge cap

$104.73-$0.17 (-0.2%)

Last close · Data as of Nov 20, 2026

Market cap
$10.8B
P/E
13.4x
EV / EBITDA
9.8x
Revenue
$7.1B
Net margin
11.4%
ROCE
32.3%

+4.7% over the last year

The Clorox Company price, 1Y

Daily closes.

Go deeper

Technical chart: candles, 28 indicators including moving averages, RSI and MACD, drawing tools and five colour themes

Open technical chart
Open technical chartCandles, 28 indicators, drawing tools

Performance

Price return, before dividends, to the 20 Nov 2026 close.

1M
+19.8%
3M
-1.2%
6M
+11.1%
1Y
+4.7%
5Y
-37.3%

52-week range

Day change -$0.17 (-0.2%) from $105 to $105 · Last close Nov 20, 2026

Best weekday to invest, historically

The same weekly amount in CLX, bought on each weekday since 2021.

News & filings

What The Clorox Company filed, who traded, and what's next

How to read this

"News & filings" lists what the company itself has put on record with regulators, who inside it traded, the news that names it, and the next date we know of. Filings and releases are first-hand; news is third-party and may be thin for smaller companies. A day of insider filings is one row. Nothing here is a recommendation.

AI Summary

US Stock

StrengthReturn on capital employed of 32.3%.

Concerns (1)

  • Current assets are 0.84 times current liabilities.
  • Shareholders' equity is small against the company's size, so return on equity and debt to equity are not shown.

Prices to the 20 Nov 2026 close · Financial year: fiscal 2025

Rule-based from financial data. Not advice.

About the company

The Clorox Company manufactures and markets consumer and professional products worldwide. The company operates through four segments: Health and Wellness, Household, Lifestyle, and International.

Read moreShow less

The Clorox Company manufactures and markets consumer and professional products worldwide. The company operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers home care cleaning and disinfecting products, bleach, clog removers, and laundry additives under the Clorox, Clorox2, Pine-Sol, Scentiva, Tilex, Liquid-Plumr, Poett, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand in the United States. The Household segment provides cat litter products under the Fresh Step and Scoop Away brands; bags and wraps under the Glad brand; and grilling products under the Kingsford brand in the United States. The Lifestyle segment offers dressings, dips, seasonings, and sauces primarily under the Hidden Valley brand; water-filtration products under the Brita brand; and natural personal care products under the Burt's Bees brand in the United States. The International segment provides laundry additives, home care products, bags and wraps, cat litter products, water-filtration systems, professional cleaning and disinfecting products, natural personal care products, food, grilling products, and digestive health products internationally primarily under the Clorox, Glad, Poett, Brita, Burt's Bees, Pine-Sol, Ever Clean, Clorinda, Chux and Fresh Step Brands. It also offers vitamins, minerals, and supplement products under the Natural Vitality, RenewLife, NeoCell, and Rainbow Light brands. The company sells its products through mass retailers; grocery outlets; warehouse clubs; dollar stores; home hardware centers; drug, pet, and military stores; third-party and owned e-commerce channels; and distributors, as well as a direct sales force. The company was founded in 1913 and is headquartered in Oakland, California.

Sector
Consumer Defensive
Shares outstanding
122.7M

Valuation, profitability, growth and solvency at the latest close; hover a label for its meaning.

Valuation

Market cap
$10.8B
P/E
13.4x
P/B
33.8x
EV / EBITDA
9.8x
EV / Sales
1.9x
P/S
1.5x
52-week high
$127.16
52-week low
$80.41

Profitability

Operating margin
16.6%
Net margin
11.4%
EBITDA margin
19.5%
ROE
252.3%
ROCE
32.3%
ROA
14.6%
Asset turnover
1.28

Growth

Revenue
$7.1B
Revenue growth, 1Y
0.2%
Revenue CAGR, 3Y
-0.0%
Net profit growth, 1Y
189.3%
Free cash flow
$761.0M

Solvency

Current ratio
0.84
Debt / Equity
8.97
Debt / Assets
0.52
CFO / Net profit
1.21
Cash / Market cap
1.5%

Where the revenue went

Of every $100 of FY2025 revenue, $11 was left as net income.

The Clorox Company income statement flow, FY2025
The Clorox Company income statement flow, FY2025: flows
FromToAmount
RevenueCost of revenue$3.9B
RevenueGross profit$3.2B
Gross profitResearch and development$121.0M
Gross profitSelling, general and administrative$1.9B
Gross profitOther operating expenses$21.0M
Gross profitOperating income$1.2B
Operating incomePretax income$1.1B
Operating incomeInterest and other expense$99.0M
Pretax incomeTax and other$268.0M
Pretax incomeNet income$810.0M

Revenue and net profit

Revenue grew 0.2% in FY2025; net profit is the dashed line.

The Clorox Company revenue and net profit by fiscal year
The Clorox Company revenue and net profit by fiscal year
DateRevenueNet profit
FY2022$7.1B$462.0M
FY2023$7.4B$149.0M
FY2024$7.1B$280.0M
FY2025$7.1B$810.0M

Cash flows

FY2025: $981.0M from operations, $761.0M free after investment (dashed).

The Clorox Company operating and free cash flow by fiscal year
The Clorox Company operating and free cash flow by fiscal year
DateOperating cash flowFree cash flow
FY2022$786.0M$535.0M
FY2023$1.2B$930.0M
FY2024$695.0M$483.0M
FY2025$981.0M$761.0M

Growth

Latest fiscal year 2025: each figure with its change over the year before.

Revenue
$7.1B+0.2%1Y
EBITDA
$1.4B+91.6%1Y
Net profit
$810.0M+189.3%1Y
Cash from operations
$981.0M+41.2%1Y
Free cash flow
$761.0M+57.6%1Y
Revenue CAGR, 3Y
-0.0%
Net profit CAGR, 3Y
20.6%
YearRevenueEBITDANet profitFCFROERevenue growth 1YNet profit growth 1Y
FY2025$7.1B$1.4B$810.0M$761.0M252.3%+0.2%+189.3%

Monthly returns

Month-by-month returns of CLX across the years, with the seasonal pattern.

Balance sheet

What the company owns and owes at the end of FY2025.

LineFY2025
Assets$5.6B
Liabilities$5.1B
Equity$482.0M
Paid-in capital$1.3B
Retained earnings$432.0M
Treasury stock$1.4B
Minority interest$161.0M

Market cap against peers

8 peers: same sector, nearest by size.

Peers map

Consumer Defensive companies placed by value, growth and quality; CLX highlighted.

P/E against peers

CLX trades at 13.4x earnings against a peer median of 16.1x (a 17% discount).

Not shown (no positive earnings and no EV / Sales): The J. M. Smucker Company.

Peer comparison

Same-sector peers by market cap, with the median.

CompanyMarket capP/EP/BROEEV/EBITDA
The Clorox CompanyCLXthis companyP/E ↓ discount$10.8B13.4x33.8x252.3%9.8x
Church & Dwight Co., Inc.CHD$22.3B30.3x5.6x18.4%18.5x
Dollar Tree, Inc.DLTR$21.0B16.4x5.6x34.2%11.6x
Tyson Foods, Inc.TSN$20.0B42.3x1.1x2.6%10.7x
General Mills, Inc.GIS$17.2B7.5x1.9x24.9%8.2x
Hormel Foods CorporationHRL$12.8B26.8x1.6x6.1%14.9x
McCormick & Company, IncorporatedMKC$12.5B15.9x2.2x13.8%12.4x
Brown-Forman CorporationBF-B$11.7B13.4x2.9x21.8%10.8x
The J. M. Smucker CompanySJM$10.8B-8.8x1.8x-20.2%-118.7x
Peer median—16.1x2.0x16.1%11.2x

Year-to-date ROI

CLX since 1 January, against earlier years.

Historical volatility

CLX's day-to-day swings over 30, 60 and 180 days.

Financial statements

Income statement, balance sheet and cash flow as reported, grouped into plain-language lines.

Consolidated figures in USD, fiscal years, newest first.

Operating margin by fiscal year

The Clorox Company operating margin by fiscal year
The Clorox Company operating margin by fiscal year
DateOperating margin
FY202210.1%
FY202311.1%
FY202410.2%
FY202516.6%
LineFY2025
Cost of revenueCost Of Revenue$3.9B
Gross profitGross Profit$3.2B
Operating expensesOperating Expense$2.0B
Research and developmentResearch And Development$121.0M
Other operating expensesOther Operating Expenses—
Depreciation and amortisationDepreciation And Amortization In Income Statement$21.0M
Depreciation, amortisation and depletionDepreciation Amortization Depletion Income Statement$21.0M
Amortization$21.0M
Amortisation of intangiblesAmortization Of Intangibles Income Statement$21.0M
Total expensesTotal Expenses$5.9B
Operating incomeOperating Income$1.2B
Pretax incomePretax Income$1.1B

Learn while you research

Academy chapters picked for The Clorox Company and the metrics on this page.

  1. 01 Stock Valuation BasicsHow to think about what a fair price for a stock looks like.7 min read
  2. 02 Leverage RatiosDebt/Equity of 8.97 is elevated, understand what that means for solvency.6 min read
  3. 03 Cyclical vs Defensive StocksConsumer staples behave defensively across the business cycle.6 min read
  4. 04 Essential Stock RatiosP/E, P/B, EV/EBITDA, what they mean and when to use each.7 min read
  5. 05 How to Read a Cash-Flow StatementProfit can be manipulated; cash flow rarely lies.7 min read
Browse the full Equiscale Academy →